NFKB1 and gram-negative bacterial infections: Promoter binding by NF-κB or pharmacological inhibition of IKK signalling was used previously to show regulation of miR-146a and miR-155 expression upon Gram-negative bacterial infections or LPS stimulation in several independent studies [15], [21], [23], [37]–[38].